EXAS - EXACT SCIENCES CORP

104.91
0.990   0.944%

Share volume: 21,562,141
Last Updated: 03-20-2026
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$103.92
0.99
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 0%
Dept financing 27%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
1.51%
3 Months
2.92%
6 Months
96.53%
1 Year
142.34%
2 Year
49.00%
Key data
Stock price
$104.91
P/E Ratio 
0.00
DAY RANGE
$104.90 - $104.98
EPS 
-$1.10
52 WEEK RANGE
$38.81 - $104.98
52 WEEK CHANGE
$142.34
MARKET CAP 
19.243 B
YIELD 
N/A
SHARES OUTSTANDING 
190.888 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.40
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$11,727,277
AVERAGE 30 VOLUME 
$3,401,883
Company detail
CEO: Kevin T. Conroy
Region: US
Website: exactsciences.com
Employees: 6,400
IPO year: 2001
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Exact Sciences Corporation provides cancer screening and diagnostic test products. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers.

Recent news